What is the size of Blood Glucose Monitoring Devices Market?
According to 6Wresearch internal database and industry insights, the Blood Glucose Monitoring Devices Market was valued at USD 15.0 Billion in 2025 and is expected to reach USD 23.9 Billion by 2032, growing at a CAGR of 6.9 % during 2026-2032F.
The key drivers for this growth are an increase in diabetes prevalence in populations, a greater emphasis on self-monitoring and self-management of healthcare, and a growing use of new sensor technologies that allow continuous monitoring and effective outcomes for patients.
Growth Factors for Blood Glucose Monitoring Devices Industry
- Increased demand for wearable and minimally invasive glucose monitoring systems to enhance patient convenience and adherence.
- Increased demand for continuous glucose monitoring (CGM) devices, in addition to traditional self-monitoring devices, to enhance patient disease management outcomes.
- A greater emphasis on home care and remote monitoring services necessitating device utilization and a new trend within the industry.
- Advances in connectivity to data analytics, smart devices and smartphones that allows providers and patients to offer new approaches and value propositions to their health.
- Expanding forms of reimbursement and regional support policies driving device uptake and market.
Blood Glucose Monitoring Devices Market Trends
The Blood Glucose Monitoring Devices Market trends show a move towards real-time continuous glucose monitoring systems and connections to mobile health applications. These developments deliver improved data insights for patients using the technology, as well as real-time connections to health care providers. Smart, minimally invasive and wearable glucose monitoring devices are becoming more widespread, which interface with cloud applications and are filled with data to be shared with patients and clinicians.
Emerging Developments in the Blood Glucose Monitoring Devices Market
The Blood Glucose Monitoring Devices Market developments are in to allow the emergence of implantable and sensor monitoring systems with extended wear time and limited user interface, along with AI analytics to assist in predicting glucose trends and enabling proactive intervention. Device companies are also working on skin-patch monitors and non-invasive optical ways to monitor glucose levels. E-commerce and direct-to-consumer subscription models are enabling more access and a wider geographical reach into the market.
List of Leading Companies in the Blood Glucose Monitoring Devices Market
Some of the leading companies include:
- Abbott Laboratories
- Dexcom Inc.
- F. Hoffmann-La Roche Ltd.
- Medtronic plc
- Ascensia Diabetes Care
- LifeScan Inc.
- Senseonics Holdings, Inc.
Frequently Asked Questions About the Market Study (FAQs):
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com